The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Drugmaker Wockhardt on Thursday announced Central Drugs Standard Control Organization (CDSCO) approval for use of ... plans to launch Miqnaf in the Indian market in coming few months, Wockhardt ...

Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

The CDSCO, which is the apex body responsible for approval of new drugs and clinical trials, has issued an alert regarding this. According to latest data, they found 41 batches of drugs ...

MannKind (MNKD) and Cipla announced that the Central Drugs Standard Control Organisation in India has approved Afrezza Inhalation Powder in adults. The CDSCO decision follows existing approvals in ...

The Central Drugs Standard Control Organisation (CDSCO) has banned the import of refurbished medical devices, reinforcing India’s commitment to patient safety and strengthening the local industry's ...

NEW DELHI: Central Drugs Standard Control Organisation (CDSCO) and Drugs Control Directorate ... to prove their legitimate import into India. The investigating team also discovered several empty ...

The share price of Wockhardt rose by 5 per cent in the Friday trading session following the approval ... by the Indian drug regulator. The Central Drugs Standard Control Organisation (CDSCO ...

“India’s decision to waive local clinical trials for drugs ... of CDSCO as early as 2023. Also voices from the industry, state that the move will expedite the approval process for new drugs ...